Antiplatelet treatment and gastro-intestinal hemorrhage risk
Ratio of atherothrombotic risk and risk of hemorrhage complications should be estimated before aspirin prescription as a component of cardiovascular event prevention. It is unlikely that there exists a daily aspirin dose, possessing antiplatelet efficacy, but without gastro-intestinal (GI) hemorrhag...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2005-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/995 |